The most common grade @ or worse adverse events for patients treated with vorinostat were fatigue or malaise ( @ -LSB- @ % -RSB- patients in the vorinostat group vs @ -LSB- @ % -RSB- in the placebo group -RSB- ) and dyspnoea ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) .